Detalhe da pesquisa
1.
Atezolizumab plus modified docetaxel, cisplatin, and fluorouracil as first-line treatment for advanced anal cancer (SCARCE C17-02 PRODIGE 60): a randomised, non-comparative, phase 2 study.
Lancet Oncol
; 25(4): 518-528, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38547895
2.
Bevacizumab plus FOLFIRI after failure of platinum-etoposide first-line chemotherapy in patients with advanced neuroendocrine carcinoma (PRODIGE 41-BEVANEC): a randomised, multicentre, non-comparative, open-label, phase 2 trial.
Lancet Oncol
; 24(3): 297-306, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36739879
3.
Optimal treatment strategy after first-line induction therapy in advanced HER2-positive oeso-gastric adenocarcinoma-a retrospective, international, multicentric AGEO study.
Gastric Cancer
; 26(3): 425-437, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36881202
4.
The safety and efficacy of total mesorectal excision (TME) surgery following dose-escalation: Surgical outcomes from the organ preservation in early rectal adenocarcinoma (OPERA) trial, a European multicentre phase 3 randomised trial (NCT02505750).
Colorectal Dis
; 25(11): 2160-2169, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37837240
5.
Chemotherapy (doublet or triplet) plus targeted therapy by RAS status as conversion therapy in colorectal cancer patients with initially unresectable liver-only metastases. The UNICANCER PRODIGE-14 randomised clinical trial.
Br J Cancer
; 126(9): 1264-1270, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34992255
6.
Phase II study evaluating the association of gemcitabine, trastuzumab and erlotinib as first-line treatment in patients with metastatic pancreatic adenocarcinoma (GATE 1).
Int J Cancer
; 148(3): 682-691, 2021 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33405269
7.
Sphincter-saving surgery for ultra-low rectal carcinoma initially indicated for abdominoperineal resection: Is it safe on a long-term follow-up?
J Surg Oncol
; 123(1): 299-310, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33098678
8.
Withholding the Introduction of Anti-Epidermal Growth Factor Receptor: Impact on Outcomes in RAS Wild-Type Metastatic Colorectal Tumors: A Multicenter AGEO Study (the WAIT or ACT Study).
Oncologist
; 25(2): e266-e275, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32043796
9.
Does A Longer Waiting Period After Neoadjuvant Radio-chemotherapy Improve the Oncological Prognosis of Rectal Cancer?: Three Years' Follow-up Results of the Greccar-6 Randomized Multicenter Trial.
Ann Surg
; 270(5): 747-754, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31634178
10.
Panitumumab use in metastatic colorectal cancer and patterns of RAS testing: results from a Europe-wide physician survey and medical records review.
BMC Cancer
; 17(1): 798, 2017 Nov 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-29183279
11.
[Hepatic myelolipoma: A rare entity, case report and review of the literature]. / Myélolipome hépatique : une entité rare, à propos d'un cas et revue de la littérature.
Ann Pathol
; 37(5): 415-419, 2017 Oct.
Artigo
em Francês
| MEDLINE | ID: mdl-28935415
12.
Prognostic nomogram and score to predict overall survival in locally advanced untreated pancreatic cancer (PROLAP).
Br J Cancer
; 115(3): 281-9, 2016 Jul 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-27404456
13.
Impact of tumour RAS/BRAF status in a first-line study of panitumumab + FOLFIRI in patients with metastatic colorectal cancer.
Br J Cancer
; 115(10): 1215-1222, 2016 Nov 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27764839
14.
High Resectability Rate of Initially Unresectable Colorectal Liver Metastases After UGT1A1-Adapted High-Dose Irinotecan Combined with LV5FU2 and Cetuximab: A Multicenter Phase II Study (ERBIFORT).
Ann Surg Oncol
; 23(7): 2161-6, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-26739304
15.
Survival, safety, and prognostic factors for outcome with Regorafenib in patients with metastatic colorectal cancer refractory to standard therapies: results from a multicenter study (REBECCA) nested within a compassionate use program.
BMC Cancer
; 16: 412, 2016 07 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27389564
16.
Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib: The LAP07 Randomized Clinical Trial.
JAMA
; 315(17): 1844-53, 2016 May 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27139057
17.
Analysis of circulating DNA and protein biomarkers to predict the clinical activity of regorafenib and assess prognosis in patients with metastatic colorectal cancer: a retrospective, exploratory analysis of the CORRECT trial.
Lancet Oncol
; 16(8): 937-48, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26184520
18.
Chemotherapy treatment patterns and neutropenia management in gastric cancer.
Gastric Cancer
; 18(2): 360-7, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24792482
19.
Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study.
Lancet Oncol
; 15(2): 184-90, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24440473
20.
Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial.
Lancet
; 381(9863): 303-12, 2013 Jan 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-23177514